ForSight Robotics
ForSight Robotics raises $125M Series B at $700M valuation
Quick Facts
ForSight Robotics: Series B Funding Round
ForSight Robotics has successfully raised $125M in Series B funding, reaching a valuation of $700M.
Company Overview
Ophthalmic surgical robots
Funding Details
The Series B round was led by Eclipse Ventures, with participation from Vensana Capital.
Company Information
- Headquarters: Menlo Park, CA
- Founded: 2018
- Employees: 200+
- Category: MedTech
Investment
ForSight Robotics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Eclipse Ventures: Verified investor in Series B
- Vensana Capital: Verified investor in Series B
Key Investors
About the Author
Related Company Reports
Galvenize Therapeutics Raises $100M Series C to Transform MedTech
Galvenize Therapeutics has secured $100M Series C in funding to accelerate growth and innovation in the medtech sector. Medical device company developing pulsed electric field therapies for cardiac ablation and tumor treatment...
Reprieve Cardiovascular Raises $61M Series B to Transform MedTech
Reprieve Cardiovascular has secured $61M Series B in funding to accelerate growth and innovation in the medtech sector. Cardiovascular device company developing personalized heart failure therapies and monitoring solutions...
ViCentra Raises $85M Series D to Transform MedTech
ViCentra has secured $85M Series D in funding to accelerate growth and innovation in the medtech sector. Medical device company developing innovative insulin patch pumps for diabetes management...
